595 related articles for article (PubMed ID: 34564742)
41. Assessment of commercial SARS-CoV-2 antibody assays, Jamaica.
Butterfield TR; Bruce-Mowatt A; Phillips YZR; Brown N; Francis K; Brown J; Walker JP; McKnight NAL; Ehikhametalor K; Taylor DK; Bruce CA; McGrowder D; Wharfe G; Sandiford SL; Thompson TK; Anzinger JJ
Int J Infect Dis; 2021 Apr; 105():333-336. PubMed ID: 33610776
[TBL] [Abstract][Full Text] [Related]
42. Seropositivity rate and diagnostic accuracy of serological tests in 2019-nCoV cases: a pooled analysis of individual studies.
Guo CC; Mi JQ; Nie H
Eur Rev Med Pharmacol Sci; 2020 Oct; 24(19):10208-10218. PubMed ID: 33090430
[TBL] [Abstract][Full Text] [Related]
43. Clinical characteristics and antibody response to SARS-CoV-2 spike 1 protein using VITROS Anti-SARS-CoV-2 antibody tests in COVID-19 patients in Japan.
Nagura-Ikeda M; Imai K; Kubota K; Noguchi S; Kitagawa Y; Matsuoka M; Tabata S; Miyoshi K; Ito T; Tamura K; Maeda T
J Med Microbiol; 2021 Apr; 70(4):. PubMed ID: 33861191
[No Abstract] [Full Text] [Related]
44. Single-Dilution COVID-19 Antibody Test with Qualitative and Quantitative Readouts.
Bortz RH; Florez C; Laudermilch E; Wirchnianski AS; Lasso G; Malonis RJ; Georgiev GI; Vergnolle O; Herrera NG; Morano NC; Campbell ST; Orner EP; Mengotto A; Dieterle ME; Fels JM; Haslwanter D; Jangra RK; Celikgil A; Kimmel D; Lee JH; Mariano MC; Nakouzi A; Quiroz J; Rivera J; Szymczak WA; Tong K; Barnhill J; Forsell MNE; Ahlm C; Stein DT; Pirofski LA; Goldstein DY; Garforth SJ; Almo SC; Daily JP; Prystowsky MB; Faix JD; Fox AS; Weiss LM; Lai JR; Chandran K
mSphere; 2021 Apr; 6(2):. PubMed ID: 33883259
[TBL] [Abstract][Full Text] [Related]
45. A Trans-Governmental Collaboration to Independently Evaluate SARS-CoV-2 Serology Assays.
Pinto LA; Shawar RM; O'Leary B; Kemp TJ; Cherry J; Thornburg N; Miller CN; Gallagher PS; Stenzel T; Schuck B; Owen SM; Kondratovich M; Satheshkumar PS; Schuh A; Lester S; Cassetti MC; Sharpless NE; Gitterman S; Lowy DR
Microbiol Spectr; 2022 Feb; 10(1):e0156421. PubMed ID: 35019677
[TBL] [Abstract][Full Text] [Related]
46. Evaluation of Orthogonal Testing Algorithm for Detection of SARS-CoV-2 IgG Antibodies.
Xu G; Emanuel AJ; Nadig S; Mehrotra S; Caddell BA; Curry SR; Nolte FS; Babic N
Clin Chem; 2020 Dec; 66(12):1531-1537. PubMed ID: 32894753
[TBL] [Abstract][Full Text] [Related]
47. Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2.
Djukic T; Mladenovic M; Stanic-Vucinic D; Radosavljevic J; Smiljanic K; Sabljic L; Devic M; Cujic D; Vasovic T; Simovic A; Radomirovic M; Cirkovic Velickovic T
Virology; 2021 May; 557():15-22. PubMed ID: 33582454
[TBL] [Abstract][Full Text] [Related]
48. Comparative analysis of the main haematological indexes and RNA detection for the diagnosis of SARS-CoV-2 infection.
Xiang J; Chen Z; Zhou J; Tian D; Ran X; Zhang Z; Shi S; Xiao D; Zhou Y
BMC Infect Dis; 2020 Oct; 20(1):779. PubMed ID: 33081702
[TBL] [Abstract][Full Text] [Related]
49. Highlighted Prospects of an IgM/IgG Antibodies Test in Identifying Individuals With Asymptomatic Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection.
Li Y; He Q; Yu R; Jiang H; Wang W; Feng D; Hou G; Zhou H; Jiang Y; Xiang Z
Arch Pathol Lab Med; 2021 Jan; 145(1):39-45. PubMed ID: 32966561
[TBL] [Abstract][Full Text] [Related]
50. Evaluation of the performance of SARS-CoV-2 serological tools and their positioning in COVID-19 diagnostic strategies.
Velay A; Gallais F; Benotmane I; Wendling MJ; Danion F; Collange O; De Sèze J; Schmidt-Mutter C; Schneider F; Bilbault P; Meziani F; Fafi-Kremer S
Diagn Microbiol Infect Dis; 2020 Dec; 98(4):115181. PubMed ID: 32957073
[TBL] [Abstract][Full Text] [Related]
51. Sars-Cov-2 Infection Screening Using Two Serological Testing Methods.
Arinola OG; Edem VF; Rahamon SK; Yaqub SA; Fashina AO; Alonge TO
Niger J Physiol Sci; 2020 Dec; 35(2):117-121. PubMed ID: 34009193
[TBL] [Abstract][Full Text] [Related]
52. Performance of 30 commercial SARS-CoV-2 serology assays in testing symptomatic COVID-19 patients.
Vauloup-Fellous C; Maylin S; Périllaud-Dubois C; Brichler S; Alloui C; Gordien E; Rameix-Welti MA; Gault E; Moreau F; Fourati S; Challine D; Pawlotsky JM; Houhou-Fidouh N; Damond F; Mackiewicz V; Charpentier C; Méritet JF; Rozenberg F; Podglajen I; Marot S; Petit H; Burrel S; Akhavan S; Leruez-Ville M; Avettand-Fenoel V; Fourgeaud J; Guilleminot T; Gardiennet E; Bonacorsi S; Carol A; Carcelain G; Villemonteix J; Boukli N; Gozlan J; Morand-Joubert L; Legoff J; Delaugerre C; Chaix ML; Roque-Afonso AM; Dortet L; Naas T; Ronat JB; Lepape S; Marcelin AG; Descamps D
Eur J Clin Microbiol Infect Dis; 2021 Oct; 40(10):2235-2241. PubMed ID: 33782783
[TBL] [Abstract][Full Text] [Related]
53. Operational characteristics of 30 lateral flow immunoassays used to identify COVID-19 immune response.
David A; Scott L; Jugwanth S; Gededzha M; Kahamba T; Zwane N; Mampeule N; Sanne I; Stevens W; Mayne ES
J Immunol Methods; 2021 Sep; 496():113096. PubMed ID: 34242653
[TBL] [Abstract][Full Text] [Related]
54. Evaluating 10 Commercially Available SARS-CoV-2 Rapid Serological Tests by Use of the STARD (Standards for Reporting of Diagnostic Accuracy Studies) Method.
Dortet L; Ronat JB; Vauloup-Fellous C; Langendorf C; Mendels DA; Emeraud C; Oueslati S; Girlich D; Chauvin A; Afdjei A; Bernabeu S; Le Pape S; Kallala R; Rochard A; Verstuyft C; Fortineau N; Roque-Afonso AM; Naas T
J Clin Microbiol; 2021 Jan; 59(2):. PubMed ID: 33239381
[TBL] [Abstract][Full Text] [Related]
55. Longitudinal SARS-CoV-2 antibody study using the Easy Check COVID-19 IgM/IgG™ lateral flow assay.
Higgins RL; Rawlings SA; Case J; Lee FY; Chan CW; Barrick B; Burger ZC; Yeo KJ; Marrinucci D
PLoS One; 2021; 16(3):e0247797. PubMed ID: 33661960
[TBL] [Abstract][Full Text] [Related]
56. Validation of COVID-19 serologic tests and large scale screening of asymptomatic healthcare workers.
Mullins KE; Merrill V; Ward M; King B; Rock P; Caswell M; Ahlman M; Harris AD; Christenson R
Clin Biochem; 2021 Apr; 90():23-27. PubMed ID: 33472036
[TBL] [Abstract][Full Text] [Related]
57. Validation and performance comparison of three SARS-CoV-2 antibody assays.
Paiva KJ; Grisson RD; Chan PA; Huard RC; Caliendo AM; Lonks JR; King E; Tang EW; Pytel-Parenteau DL; Nam GH; Yakirevich E; Lu S
J Med Virol; 2021 Feb; 93(2):916-923. PubMed ID: 32710669
[TBL] [Abstract][Full Text] [Related]
58. Clinical validation of an immunochromatographic SARS-Cov-2 IgM/IgG antibody assay with Japanese cohort.
Kaneko S; Nukui Y; Arashiro T; Aiso Y; Sugii M; Hadano Y; Nagata K; Taki R; Ueda K; Hanada S; Suzaki S; Harada N; Yamaguchi Y; Nakanishi H; Kurosaki M; Nagasawa M; Izumi N
J Med Virol; 2021 Jan; 93(1):569-572. PubMed ID: 32720704
[TBL] [Abstract][Full Text] [Related]
59. Persistence of SARS-CoV-2-Specific Antibodies for 13 Months after Infection.
Kučinskaitė-Kodzė I; Simanavičius M; Šimaitis A; Žvirblienė A
Viruses; 2021 Nov; 13(11):. PubMed ID: 34835119
[TBL] [Abstract][Full Text] [Related]
60. Performance Evaluation of the Siemens SARS-CoV-2 Total Antibody and IgG Antibody Test.
Florin L; Maelegheer K; Vandewal W; Bernard D; Robbrecht J
Lab Med; 2021 Nov; 52(6):e147-e153. PubMed ID: 33928377
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
